Menopausal Hot Flashes Global Clinical Trials Review, H2, 2015

1
Menopausal Hot Flashes Global Clinical Trials
Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Menopausal Hot Flashes Global Clinical Trials
  Review, H2, 2015 provides an overview of
  Menopausal Hot Flashes clinical trials scenario.
  This report provides top line data relating to
  the clinical trials on Menopausal Hot Flashes.
  Report includes an overview of trial numbers and
  their average enrollment in top countries
  conducted across the globe. The report offers
  coverage of disease clinical trials by region,
  country (G7 E7), phase, trial status, end
  points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials).
• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• - Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/menopaus
  al-hot-flashes-global-clinical-trials-review-h2-20
  15-market

3


Table of Content
Table of Contents 2 List of Tables 3 List of
Figures 4 Report Guidance 5 Clinical Trials by
Region 6 Clinical Trials and Average Enrollment
by Country 7 Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 10 Top Five
Countries Contributing to Clinical Trials in
Europe 11 Top Countries Contributing to Clinical
Trials in North America 12 Top Countries
Contributing to Clinical Trials in Middle East
and Africa 13 Top Countries Contributing to
Clinical Trials in Central and South America
14 Clinical Trials by G7 Countries Proportion of
Menopausal Hot Flashes to Women's Health Clinical
Trials 15 Clinical Trials by Phase in G7
Countries 17 Clinical Trials in G7 Countries by
Trial Status 18 Clinical Trials by E7 Countries
Proportion of Menopausal Hot Flashes to Women's
Health Clinical Trials 19 Clinical Trials by
Phase in E7 Countries 21 Clinical Trials in E7
Countries by Trial Status 22 Clinical Trials by
Phase 23 In Progress Trials by Phase 24 Clinical
Trials by Trial Status 25 Clinical Trials by End
Point Status 26
4


Table of Content
Subjects Recruited Over a Period of Time
27 Clinical Trials by Sponsor Type 28 Prominent
Sponsors 29 Top Companies Participating in
Menopausal Hot Flashes Therapeutics Clinical
Trials 31 Prominent Drugs 33 Latest Clinical
Trials News on Menopausal Hot Flashes 34 Sep 23,
2015 Euroscreen launches Phase 2 clinical trial
with ESN364 as the first and unique non-hormonal
causal treatment for menopausal Hot Flashes
34 Clinical Trial Profile Snapshots 35 Appendix
94 Abbreviations 94 Definitions 94 Research
Methodology 95 Secondary Research 95 About
GlobalData 96 Contact Us 96 Disclaimer 96 Source
97 Enquire At http//www.researchbeam.com/menop
ausal-hot-flashes-global-clinical-trials-review-h2
-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/menopausal-hot-flashes
-global-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com